M.A. Moral

449 total citations
22 papers, 295 citations indexed

About

M.A. Moral is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, M.A. Moral has authored 22 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in M.A. Moral's work include Chronic Lymphocytic Leukemia Research (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). M.A. Moral is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). M.A. Moral collaborates with scholars based in Spain. M.A. Moral's co-authors include Jesús M. Paramio, Peter Revill, M. A. Mangues, Carmen M. Arroyo, J. Prous, M. Fernanda Lara, Marcelo dos Santos, Carmen Segrelles, Ramón Garcı́a-Escudero and Sergio Ruiz and has published in prestigious journals such as Oncogene, Drug News & Perspectives and Drugs of today.

In The Last Decade

M.A. Moral

19 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Moral Spain 7 160 67 58 33 25 22 295
Yan Xi China 11 188 1.2× 62 0.9× 37 0.6× 27 0.8× 22 0.9× 24 326
Guoqiang Song China 12 165 1.0× 44 0.7× 25 0.4× 37 1.1× 18 0.7× 25 313
Angela Cisneros United States 8 237 1.5× 31 0.5× 57 1.0× 16 0.5× 22 0.9× 13 395
Ajeet Kumar Verma India 11 187 1.2× 38 0.6× 72 1.2× 33 1.0× 31 1.2× 16 349
Xiaofang Guo China 13 188 1.2× 67 1.0× 83 1.4× 27 0.8× 42 1.7× 35 388
Ana Nedeljkovic-Kurepa United States 7 249 1.6× 19 0.3× 107 1.8× 46 1.4× 23 0.9× 11 464
Daohua Shi China 13 247 1.5× 29 0.4× 48 0.8× 32 1.0× 21 0.8× 24 389
Robyn T. Bilinski United States 8 232 1.4× 103 1.5× 130 2.2× 16 0.5× 32 1.3× 11 547
Wen Qin-sheng China 9 258 1.6× 20 0.3× 43 0.7× 59 1.8× 25 1.0× 17 401
Sidong Song China 10 80 0.5× 24 0.4× 74 1.3× 95 2.9× 25 1.0× 11 352

Countries citing papers authored by M.A. Moral

Since Specialization
Citations

This map shows the geographic impact of M.A. Moral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Moral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Moral more than expected).

Fields of papers citing papers by M.A. Moral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Moral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Moral. The network helps show where M.A. Moral may publish in the future.

Co-authorship network of co-authors of M.A. Moral

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Moral. A scholar is included among the top collaborators of M.A. Moral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Moral. M.A. Moral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moral, M.A., et al.. (2010). Gateways to clinical trials. Methods and Findings in Experimental and Clinical Pharmacology. 32(4). 247–247. 6 indexed citations
2.
Moral, M.A., et al.. (2010). Gateways to clinical trials. Methods and Findings in Experimental and Clinical Pharmacology. 32(9). 675–675. 36 indexed citations
3.
Moral, M.A., et al.. (2008). Gateways to clinical trials. July-August 2008.. PubMed. 30(6). 459–95. 2 indexed citations
4.
Moral, M.A. & Jesús M. Paramio. (2008). Akt pathway as a target for therapeutic intervention in HNSCC.. PubMed. 23(10). 1269–78. 47 indexed citations
5.
Moral, M.A., et al.. (2007). Personality disorders. Drugs of the Future. 32(8). 713–713. 1 indexed citations
6.
Ferrer, Elisa, M.A. Moral, & Jordi Bozzo. (2007). The role of statins in erectile dysfunction. Drugs of today. 43(1). 55–55. 6 indexed citations
7.
Moral, M.A., et al.. (2007). Lymphangioleiomyomatosis. Drugs of the Future. 32(8). 723–723.
8.
Moral, M.A., et al.. (2007). Seasonal affective disorder. Drugs of the Future. 32(5). 457–457. 2 indexed citations
9.
McIntyre, Jennifer, et al.. (2007). Combination therapy with valproic acid in cancer: Initial clinical approach. Drugs of the Future. 32(1). 45–45. 9 indexed citations
10.
Moral, M.A., et al.. (2007). Graves' disease. Drugs of the Future. 32(6). 555–555.
11.
Davies, Sarah L. & M.A. Moral. (2007). Neuronal ceroid lipofuscinosis. Drugs of the Future. 32(1). 79–79. 2 indexed citations
12.
Moral, M.A., et al.. (2007). Retinitis pigmentosa. Drugs of the Future. 32(11). 991–991. 1 indexed citations
13.
Ferrer, Elisa, M.A. Moral, & Jordi Bozzo. (2007). Spotlight on autoimmune lymphoproliferative syndrome.. PubMed. 20(4). 260–2. 3 indexed citations
14.
Moral, M.A., et al.. (2007). Salicylates targeting insulin resistance. Drugs of the Future. 32(4). 361–361. 3 indexed citations
15.
Revill, Peter, M.A. Moral, & J. Prous. (2006). Impaired insulin signaling and the pathogenesis of Alzheimer'sdisease. Drugs of today. 42(12). 785–785. 23 indexed citations
16.
Moral, M.A., et al.. (2006). Augmentation in treatment-resistant depression. Drugs of the Future. 31(12). 1069–1069. 6 indexed citations
17.
Moral, M.A., et al.. (2006). Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.. PubMed. 19(10). 632–3. 2 indexed citations
18.
Segrelles, Carmen, M.A. Moral, M. Fernanda Lara, et al.. (2005). Molecular determinants of Akt-induced keratinocyte transformation. Oncogene. 25(8). 1174–1185. 74 indexed citations
19.
Moral, M.A., et al.. (2005). Chronicles in Drug Discovery. Drug News & Perspectives. 18(4). 277–277. 17 indexed citations
20.
Arroyo, Carmen M., et al.. (1997). Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients. Journal of Chromatography B Biomedical Sciences and Applications. 692(1). 127–132. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Xi Breakdown of academic impact, for papers by Guoqiang Song Breakdown of academic impact, for papers by Angela Cisneros Breakdown of academic impact, for papers by Ajeet Kumar Verma Breakdown of academic impact, for papers by Xiaofang Guo Breakdown of academic impact, for papers by Ana Nedeljkovic-Kurepa Breakdown of academic impact, for papers by Daohua Shi Breakdown of academic impact, for papers by Robyn T. Bilinski Breakdown of academic impact, for papers by Wen Qin-sheng Breakdown of academic impact, for papers by Sidong Song
Rankless by CCL
2026